Intestinal Disorders News

Healio Gastroenterology presents the following report on the top stories from UEG Week 2021.

The ACG published clinical practice guidelines on the preferred approach and management strategy for defecation disorders, proctalgia syndromes, hemorrhoids, anal fissures and fecal incontinence.

A survey across two continents showed that just 11% of adults could report a lack of gas-related symptoms during a 24-hour period.

Certain baseline gut microbiome features correlated with future changes in weight following intervention, according to study results published in mSystems, an open-access journal of the American Society for Microbiology.

Patients who are Black, Latino, low socioeconomic status, older or use public insurance were less likely to engage in videoconferencing visits compared with in-person or telephone visits, according to a presenter at Digestive Disease Week.

Despite ongoing COVID-19 infection control restrictions, volumes of inpatient consults for alcohol-related gastrointestinal and liver diseases had significantly decreased at the onset of the COVID-19 pandemic, but quickly returned to normal levels, according to an expert presentation during a press conference in advance of Digestive Diseases Week.

Opioid prescriptions rates for gastrointestinal conditions continue to increase, with renewals of existing prescriptions being the main driver, according to a study in the American Journal of Gastroenterology.

In this exclusive video, Jessica Allegretti, MD, MPH, director of the fecal microbiota center at Brigham and Women’s Hospital, discusses how FMT has transformed treatment in a number of GI conditions.

In this exclusive video, Satish Rao, MD, PhD, from Augusta University, discusses the current landscape of small intestine bacterial overgrowth diagnosis and the future impact of a capsule diagnostic system.

These reports include research on the impact of the microbiome on obesity, asthma and COVID-19.